AI Prediction of High-Risk Pregnancy Complications: Current Evidence, Clinical Applications, and Future Directions

Abstract

The application of artificial intelligence (AI) in obstetrics has rapidly evolved, particularly in the context of predicting high-risk pregnancy complications. Leveraging machine learning algorithms and large-scale multi-modal data, AI-driven systems have demonstrated potential in risk stratification, early diagnosis, and personalized management of conditions such as preeclampsia, gestational diabetes, preterm birth, and fetal growth restriction. This review synthesizes current evidence on AI-based predictive tools, discusses underlying mechanisms, evaluates clinical implications, and highlights emerging trends and guideline recommendations to inform clinicians and healthcare stakeholders.

Introduction

High-risk pregnancies represent a critical challenge in obstetrics, contributing significantly to maternal and neonatal morbidity and mortality worldwide. Traditional risk assessment relies on clinical judgment and a limited set of risk factors, often lacking sensitivity and specificity. The advent of AI, encompassing machine learning (ML) and deep learning (DL) techniques, offers novel opportunities to transform perinatal care through the integration of heterogeneous data sources, including electronic health records (EHRs), imaging modalities, and biomarkers. This review provides a comprehensive overview of AI's role in predicting high-risk pregnancy complications, focusing on methodological advances, clinical validation, and practical implications for healthcare providers.

Epidemiology / Disease Burden

Globally, complications arising from high-risk pregnancies account for substantial maternal and neonatal adverse outcomes. The World Health Organization estimates that approximately 15% of pregnant women experience conditions that could threaten their lives or that of their babies. Preeclampsia affects 2–8% of pregnancies, gestational diabetes up to 14%, and preterm birth remains the leading cause of neonatal mortality. Despite advances in antenatal care, the burden persists, particularly in resource-limited settings, highlighting the unmet need for early and accurate risk identification. AI-based prediction models promise to bridge this gap by enhancing the precision of risk stratification and enabling timely interventions.

Pathophysiology

Pregnancy complications such as preeclampsia, gestational diabetes, and preterm birth are multifactorial, involving complex interactions among genetic, environmental, immunological, and metabolic factors. For instance, preeclampsia is characterized by abnormal placentation, endothelial dysfunction, and systemic inflammation, while gestational diabetes results from pancreatic β-cell dysfunction superimposed on insulin resistance. Preterm birth mechanisms include maternal infection, cervical insufficiency, and placental pathology. AI systems can integrate these diverse pathophysiological variables, uncovering latent patterns and nonlinear associations that may elude conventional analytic methods.

Risk Factors

Established risk factors for high-risk pregnancy complications encompass maternal age, obesity, pre-existing hypertension or diabetes, multiparity, prior obstetric history, and socioeconomic determinants. Laboratory markers (e.g., elevated sFlt-1/PlGF ratio, HbA1c) and imaging findings (e.g., uterine artery Doppler indices) further refine risk stratification. AI algorithms can assimilate both structured and unstructured data, including genomic information and lifestyle parameters, to model individualized risk profiles and support shared decision-making in clinical practice.

Clinical Features

Clinical manifestations of high-risk pregnancy complications are heterogeneous. Preeclampsia typically presents with hypertension and proteinuria after 20 weeks of gestation but may progress to severe features such as eclampsia or HELLP syndrome. Gestational diabetes is often asymptomatic but associated with macrosomia and neonatal hypoglycemia. Preterm birth manifests as uterine contractions and cervical changes, with significant implications for neonatal morbidity. AI-driven predictive tools can aid clinicians in early recognition of subtle prodromal signs, optimizing surveillance and intervention strategies.

Diagnosis

Diagnosis of high-risk pregnancy complications traditionally relies on clinical criteria, laboratory assays, and imaging studies. However, limitations in sensitivity and specificity persist. AI-based models utilize supervised and unsupervised learning to analyze large datasets from EHRs, laboratory results, ultrasound images, and wearable devices. Natural language processing (NLP) enables extraction of relevant information from clinical notes. Recent studies have reported AUROC values exceeding 0.85 for AI models predicting preeclampsia and preterm birth, outperforming traditional logistic regression models. Prospective validation and external generalization remain critical for clinical adoption.

Treatment & Management

Management of high-risk pregnancies necessitates individualized care pathways, encompassing pharmacological therapy (e.g., antihypertensives, insulin), maternal-fetal monitoring, and timely delivery planning. AI can facilitate dynamic risk prediction, enabling real-time adjustments to management protocols. For instance, AI-based decision support tools can trigger alerts for escalating risk, recommend additional investigations, or suggest referral to specialist care. Integration with telemedicine platforms further extends the reach of expert oversight, particularly in underserved regions.

Recent Advances / Emerging Therapies

Recent advances in AI applications for high-risk pregnancy include deep learning models for automated ultrasound interpretation, convolutional neural networks (CNNs) for placental assessment, and reinforcement learning for optimizing treatment strategies. Federated learning frameworks allow model training across multiple institutions without compromising patient privacy. Wearable sensors and mobile health apps generate real-time physiological data, which, when processed by AI algorithms, enable continuous risk monitoring. Ongoing trials are evaluating the impact of AI-guided care pathways on perinatal outcomes, with preliminary results demonstrating improved early detection and resource allocation.

Guideline Recommendations

Professional societies increasingly recognize the potential of AI in obstetric care but emphasize the necessity for rigorous validation, transparency, and ethical oversight. The International Federation of Gynecology and Obstetrics (FIGO) and the American College of Obstetricians and Gynecologists (ACOG) recommend integration of AI-based tools as adjuncts rather than replacements for clinical judgment. Key recommendations include robust model validation, explainability, patient privacy safeguards, and clinician training. Ongoing collaboration between clinicians, data scientists, and regulatory bodies is essential to ensure safe and equitable deployment of AI technologies in maternal-fetal medicine.

Conclusion

AI prediction of high-risk pregnancy complications represents a paradigm shift in maternal-fetal medicine, offering opportunities for earlier diagnosis, personalized risk assessment, and improved clinical outcomes. While the evidence base is rapidly expanding, challenges remain in terms of model validation, generalizability, and integration into routine care. Continued multidisciplinary collaboration, adherence to ethical standards, and alignment with clinical guidelines will be critical for realizing the full potential of AI in optimizing pregnancy outcomes and advancing perinatal health.